Cite
HARVARD Citation
Einsele, H. et al. (2017). Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial. British journal of haematology. pp. 586-597. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Einsele, H. et al. (2017). Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial. British journal of haematology. pp. 586-597. [Online].